Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities

High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding domain (RBD) antibodies, SARS-CoV-2 spike-specifi...

Full description

Bibliographic Details
Published in:Nature Immunology
Main Authors: Zhang, Wuji, Kedzierski, Lukasz, Chua, Brendon Y., Mayo, Mark, Lonzi, Claire, Rigas, Vanessa, Middleton, Bianca F., McQuilten, Hayley A., Rowntree, Louise C., Allen, Lilith F., Purcell, Ruth A., Tan, Hyon-Xhi, Petersen, Jan, Chaurasia, Priyanka, Mordant, Francesca, Pogorelyy, Mikhail V., Minervina, Anastasia A., Crawford, Jeremy Chase, Perkins, Griffith B., Zhang, Eva, Gras, Stephanie, Clemens, E. Bridie, Juno, Jennifer A., Audsley, Jennifer, Khoury, David S., Holmes, Natasha E., Thevarajan, Irani, Subbarao, Kanta, Krammer, Florian, Cheng, Allen C., Davenport, Miles P., Grubor-Bauk, Branka, Coates, P. Toby, Christensen, Britt, Thomas, Paul G., Wheatley, Adam K., Kent, Stephen J., Rossjohn, Jamie, Chung, Amy W., Boffa, John, Miller, Adrian, Lynar, Sarah, Nelson, Jane, Nguyen, Thi H. O., Davies, Jane, Kedzierska, Katherine
Format: Text
Language:English
Published: Nature Publishing Group US 2023
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232372/
http://www.ncbi.nlm.nih.gov/pubmed/37248417
https://doi.org/10.1038/s41590-023-01508-y
id ftpubmed:oai:pubmedcentral.nih.gov:10232372
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:10232372 2023-06-18T03:40:37+02:00 Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities Zhang, Wuji Kedzierski, Lukasz Chua, Brendon Y. Mayo, Mark Lonzi, Claire Rigas, Vanessa Middleton, Bianca F. McQuilten, Hayley A. Rowntree, Louise C. Allen, Lilith F. Purcell, Ruth A. Tan, Hyon-Xhi Petersen, Jan Chaurasia, Priyanka Mordant, Francesca Pogorelyy, Mikhail V. Minervina, Anastasia A. Crawford, Jeremy Chase Perkins, Griffith B. Zhang, Eva Gras, Stephanie Clemens, E. Bridie Juno, Jennifer A. Audsley, Jennifer Khoury, David S. Holmes, Natasha E. Thevarajan, Irani Subbarao, Kanta Krammer, Florian Cheng, Allen C. Davenport, Miles P. Grubor-Bauk, Branka Coates, P. Toby Christensen, Britt Thomas, Paul G. Wheatley, Adam K. Kent, Stephen J. Rossjohn, Jamie Chung, Amy W. Boffa, John Miller, Adrian Lynar, Sarah Nelson, Jane Nguyen, Thi H. O. Davies, Jane Kedzierska, Katherine 2023-05-29 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232372/ http://www.ncbi.nlm.nih.gov/pubmed/37248417 https://doi.org/10.1038/s41590-023-01508-y en eng Nature Publishing Group US http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232372/ http://www.ncbi.nlm.nih.gov/pubmed/37248417 http://dx.doi.org/10.1038/s41590-023-01508-y © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . Nat Immunol Article Text 2023 ftpubmed https://doi.org/10.1038/s41590-023-01508-y 2023-06-04T01:33:12Z High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding domain (RBD) antibodies, SARS-CoV-2 spike-specific B cells, and CD4(+) and CD8(+) T cells. In First Nations participants, RBD IgG antibody titers were correlated with body mass index and negatively correlated with age. Reduced RBD antibodies, spike-specific B cells and follicular helper T cells were found in vaccinated participants with chronic conditions (diabetes, renal disease) and were strongly associated with altered glycosylation of IgG and increased interleukin-18 levels in the plasma. These immune perturbations were also found in non-Indigenous people with comorbidities, indicating that they were related to comorbidities rather than ethnicity. However, our study is of a great importance to First Nations peoples who have disproportionate rates of chronic comorbidities and provides evidence of robust immune responses after COVID-19 vaccination in Indigenous people. Text First Nations PubMed Central (PMC) Nature Immunology 24 6 966 978
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Article
spellingShingle Article
Zhang, Wuji
Kedzierski, Lukasz
Chua, Brendon Y.
Mayo, Mark
Lonzi, Claire
Rigas, Vanessa
Middleton, Bianca F.
McQuilten, Hayley A.
Rowntree, Louise C.
Allen, Lilith F.
Purcell, Ruth A.
Tan, Hyon-Xhi
Petersen, Jan
Chaurasia, Priyanka
Mordant, Francesca
Pogorelyy, Mikhail V.
Minervina, Anastasia A.
Crawford, Jeremy Chase
Perkins, Griffith B.
Zhang, Eva
Gras, Stephanie
Clemens, E. Bridie
Juno, Jennifer A.
Audsley, Jennifer
Khoury, David S.
Holmes, Natasha E.
Thevarajan, Irani
Subbarao, Kanta
Krammer, Florian
Cheng, Allen C.
Davenport, Miles P.
Grubor-Bauk, Branka
Coates, P. Toby
Christensen, Britt
Thomas, Paul G.
Wheatley, Adam K.
Kent, Stephen J.
Rossjohn, Jamie
Chung, Amy W.
Boffa, John
Miller, Adrian
Lynar, Sarah
Nelson, Jane
Nguyen, Thi H. O.
Davies, Jane
Kedzierska, Katherine
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
topic_facet Article
description High-risk groups, including Indigenous people, are at risk of severe COVID-19. Here we found that Australian First Nations peoples elicit effective immune responses to COVID-19 BNT162b2 vaccination, including neutralizing antibodies, receptor-binding domain (RBD) antibodies, SARS-CoV-2 spike-specific B cells, and CD4(+) and CD8(+) T cells. In First Nations participants, RBD IgG antibody titers were correlated with body mass index and negatively correlated with age. Reduced RBD antibodies, spike-specific B cells and follicular helper T cells were found in vaccinated participants with chronic conditions (diabetes, renal disease) and were strongly associated with altered glycosylation of IgG and increased interleukin-18 levels in the plasma. These immune perturbations were also found in non-Indigenous people with comorbidities, indicating that they were related to comorbidities rather than ethnicity. However, our study is of a great importance to First Nations peoples who have disproportionate rates of chronic comorbidities and provides evidence of robust immune responses after COVID-19 vaccination in Indigenous people.
format Text
author Zhang, Wuji
Kedzierski, Lukasz
Chua, Brendon Y.
Mayo, Mark
Lonzi, Claire
Rigas, Vanessa
Middleton, Bianca F.
McQuilten, Hayley A.
Rowntree, Louise C.
Allen, Lilith F.
Purcell, Ruth A.
Tan, Hyon-Xhi
Petersen, Jan
Chaurasia, Priyanka
Mordant, Francesca
Pogorelyy, Mikhail V.
Minervina, Anastasia A.
Crawford, Jeremy Chase
Perkins, Griffith B.
Zhang, Eva
Gras, Stephanie
Clemens, E. Bridie
Juno, Jennifer A.
Audsley, Jennifer
Khoury, David S.
Holmes, Natasha E.
Thevarajan, Irani
Subbarao, Kanta
Krammer, Florian
Cheng, Allen C.
Davenport, Miles P.
Grubor-Bauk, Branka
Coates, P. Toby
Christensen, Britt
Thomas, Paul G.
Wheatley, Adam K.
Kent, Stephen J.
Rossjohn, Jamie
Chung, Amy W.
Boffa, John
Miller, Adrian
Lynar, Sarah
Nelson, Jane
Nguyen, Thi H. O.
Davies, Jane
Kedzierska, Katherine
author_facet Zhang, Wuji
Kedzierski, Lukasz
Chua, Brendon Y.
Mayo, Mark
Lonzi, Claire
Rigas, Vanessa
Middleton, Bianca F.
McQuilten, Hayley A.
Rowntree, Louise C.
Allen, Lilith F.
Purcell, Ruth A.
Tan, Hyon-Xhi
Petersen, Jan
Chaurasia, Priyanka
Mordant, Francesca
Pogorelyy, Mikhail V.
Minervina, Anastasia A.
Crawford, Jeremy Chase
Perkins, Griffith B.
Zhang, Eva
Gras, Stephanie
Clemens, E. Bridie
Juno, Jennifer A.
Audsley, Jennifer
Khoury, David S.
Holmes, Natasha E.
Thevarajan, Irani
Subbarao, Kanta
Krammer, Florian
Cheng, Allen C.
Davenport, Miles P.
Grubor-Bauk, Branka
Coates, P. Toby
Christensen, Britt
Thomas, Paul G.
Wheatley, Adam K.
Kent, Stephen J.
Rossjohn, Jamie
Chung, Amy W.
Boffa, John
Miller, Adrian
Lynar, Sarah
Nelson, Jane
Nguyen, Thi H. O.
Davies, Jane
Kedzierska, Katherine
author_sort Zhang, Wuji
title Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
title_short Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
title_full Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
title_fullStr Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
title_full_unstemmed Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
title_sort robust and prototypical immune responses toward covid-19 vaccine in first nations peoples are impacted by comorbidities
publisher Nature Publishing Group US
publishDate 2023
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232372/
http://www.ncbi.nlm.nih.gov/pubmed/37248417
https://doi.org/10.1038/s41590-023-01508-y
genre First Nations
genre_facet First Nations
op_source Nat Immunol
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232372/
http://www.ncbi.nlm.nih.gov/pubmed/37248417
http://dx.doi.org/10.1038/s41590-023-01508-y
op_rights © The Author(s) 2023
https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
op_doi https://doi.org/10.1038/s41590-023-01508-y
container_title Nature Immunology
container_volume 24
container_issue 6
container_start_page 966
op_container_end_page 978
_version_ 1769005792415973376